In 2025, nine years after the Kigali Amendment committed nations to phasing down HFC propellants, the first low carbon pressurised Metered Dose Inhaler (pMDI) received regulatory approval. It was a landmark moment for the inhalation industry, and a signal that the transition to low Global Warming Potential (GWP) propellants has moved decisively from ambition to reality.
In our latest article for DCAT Value Chain Insights, we reflect on what the past decade has required: the manufacturing investment, the device engineering, the supply chain partnerships, and the broader ESG commitments that have brought the industry to this point.
The article also addresses what comes next — because however significant the progress, the pace of change now needs to accelerate.
Read the full article here.
